• A recent study evaluating intensive vs symptomatic-based bisphosphonate treatment in patients with Paget’s disease of the bone showed no clear clinical benefit for intensive treatment. The most recent clinical practice guidelines for treatment of Paget’s disease, however, recommend that most patients with active Paget’s disease who are at risk for future complications be treated with a bisphosphonate.
  • The Vasculitis Foundation is now accepting nominations for its fourth annual V RED Award, which honors physicians who are familiar with the disease and have offered an early diagnosis of vasculitis in a patient. “Because vasculitis is a rare disease with which many physicians have little or no familiarity, patients often spend months — or even years —seeking an accurate diagnosis,” the Foundation explained. Nominations can be submitted online, with a deadline of Monday, March 6, 2017.
  • Children with juvenile idiopathic arthritis (JIA) and obstructive sleep apnea (OSA) suffer from subsequent impaired neurobehavioral performance, a recent study from Seattle Children’s Hospital concluded. Perhaps even more significant was the study investigators’ claim that their previous research shows 40% to 50% of the patients with JIA they evaluated had OSA, yet none of them had been previously screened for a sleep disorder.
  • Catherine Leimkuhler Grimes, an assistant professor in the department of chemistry at the University of Delaware, has been awarded a Sloan Research Fellowship by the Alfred P Sloan Foundation. The 2-year, $60,000 fellowship award will help fund Dr Grimes’ research into the role of bacteria and the causes of chronic inflammatory diseases.
  • Recently published data from the European Scleroderma Observational Study (ESOS) showed no differences in outcomes among 4 treatment protocols used for systemic sclerosis. The study did show that treatment with immunosuppressants was effective for early diffuse cutaneous systemic sclerosis, but only up to 12 months.
  • In the video below, members of the division of rheumatology at Cincinnati Children’s Hospital discuss their effort to improve outcomes and care of juvenile idiopathic arthritis.

Related Articles

follow @RheumAdvisor